Found: 16
Select item for more details and to access through your institution.
Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly.
- Published in:
- EMBO Journal, 1999, v. 18, n. 16, p. 4549, doi. 10.1093/emboj/18.16.4549
- By:
- Publication type:
- Article
Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist.
- Published in:
- AAPS Journal, 2012, v. 14, n. 1, p. 68, doi. 10.1208/s12248-011-9316-3
- By:
- Publication type:
- Article
Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects.
- Published in:
- Pharmacology, 2014, v. 94, n. 3/4, p. 148, doi. 10.1159/000367630
- By:
- Publication type:
- Article
Pharmacokinetics of Macitentan in Caucasian and Japanese Subjects: The Influence of Ethnicity and Sex.
- Published in:
- Pharmacology, 2013, v. 91, n. 5/6, p. 331, doi. 10.1159/000351704
- By:
- Publication type:
- Article
Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 119, doi. 10.1111/bcp.14365
- By:
- Publication type:
- Article
Bioequivalence of macitentan and tadalafil given as fixed‐dose combination or single‐component tablets in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 12, p. 2424, doi. 10.1111/bcp.14347
- By:
- Publication type:
- Article
Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2778, doi. 10.1111/bcp.13379
- By:
- Publication type:
- Article
Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 4, p. 670, doi. 10.1111/bcp.12650
- By:
- Publication type:
- Article
Influence of different degrees of liver impairment on the pharmacokinetics of clazosentan.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 71, n. 1, p. 52, doi. 10.1111/j.1365-2125.2010.03804.x
- By:
- Publication type:
- Article
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1223, doi. 10.1007/s40261-019-00857-7
- By:
- Publication type:
- Article
A New Reversible and Potent P2Y Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 807, doi. 10.1007/s40261-014-0236-8
- By:
- Publication type:
- Article
A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 9, p. 1121, doi. 10.1007/s00228-017-2282-7
- By:
- Publication type:
- Article
Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 4, p. 409, doi. 10.1007/s00228-014-1647-4
- By:
- Publication type:
- Article
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 195, doi. 10.1007/s40256-015-0117-4
- By:
- Publication type:
- Article
A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 175, doi. 10.2147/DDDT.S75565
- By:
- Publication type:
- Article
Influence of Severe Renal Impairment on the Pharmacokinetics of Clazosentan.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 413, doi. 10.1177/0091270010368975
- By:
- Publication type:
- Article